| Stage | BLBD | % of rev | MLR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $517M | 100.00% | $212M | 100.00% | BLBD ×2.44 |
| Gross profit | $103M | 19.99% | $30M | 14.03% | BLBD +6.0pp |
| Operating income | $63M | 12.12% | $8M | 3.71% | BLBD +8.4pp |
| Pre-tax income | $197M | 38.10% | $8M | 3.54% | BLBD +34.6pp |
| Net income | $185M | 35.82% | $6M | 2.86% | BLBD +33.0pp |
| Stage | BLBD | MLR | Gap · A − B |
|---|---|---|---|
| Revenue | $517M100.00% | $212M100.00% | BLBD ×2.44 |
| Gross profit | 19.99%$103M | 14.03%$30M | BLBD +6.0pp |
| Operating income | 12.12%$63M | 3.71%$8M | BLBD +8.4pp |
| Pre-tax income | 38.10%$197M | 3.54%$8M | BLBD +34.6pp |
| Net income |
| 35.82%$185M |
| 2.86%$6M |
| BLBD +33.0pp |
No disclosed counterparties: MLR.
None